Academic pharmacist Nataly Martini provides key information on Helicobacter pylori pathophysiology, diagnosis and evidence-based treatment strategies to enhance patient outcomes
Wednesday 12 March 2025, 12:55 AM
14 minutes to Read
An important update to the COVID-19 vaccine programme
Monday 1 July 2024, 12:15 AM
Infectious disease physician Joan Ingram examines the new Comirnaty Omicron XBB.1.5 vaccine, including its effectiveness and safety
Key points, SARS-CoV-2 continues to cause hospitalisations and deaths, but at a lower rate than earlier in the pandemic as immunity increases.
Comirnaty XBB.1.5, Education Blue W/ Grey Background W/ Padding
Kia ora and welcome to Pharmacy Today Kaitiaki Rongoā O Te Wā
Not a subscriber? Unlock this article by subscribing here.
References
- Andersson NW, Thiesson EM, Hviid A. Adverse events after XBB.1.5-containing COVID-19 mRNA vaccines. JAMA 2024;331(12):1057–59.
- Gayed J, Diya O, Lowry FS, et al. Safety and immunogenicity of the monovalent Omicron XBB.1.5-adapted BNT162b2 COVID-19 vaccine in individuals ≥12 years old: A phase 2/3 trial. Vaccines (Basel) 2024;12(2):118.
- Hansen CH, Moustsen-Helms IR, Rasmussen M, et al. Short-term effectiveness of the XBB.1.5 updated COVID-19 vaccine against hospitalisation in Denmark: a national cohort study. Lancet Infect Dis 2024;24(2):e73–74.
- Link-Gelles R, Ciesla AA, Mak J, et al. Early estimates of updated 2023-2024 (monovalent XBB.1.5) COVID-19 vaccine effectiveness against symptomatic SARSCoV-2 infection attributable to co-circulating Omicron variants among immunocompetent adults – Increasing community access to testing program, United States, September 2023–January 2024. MMWR Morb Mortal Wkly Rep 2024;73(4):77–83.
- Marking U, Bladh O, Aguilera K, et al. Humoral immune responses to the monovalent XBB.1.5-adapted BNT162b2 mRNA booster in Sweden. Lancet Infect Dis 2024;24(2):e80–81.
- Markov PV, Ghafari M, Beer M, et al. The evolution of SARS-CoV-2. Nat Rev Microbiol 2023;21(6):361–79.
- Therapeutic Goods Administration. COVID-19 vaccine safety report - 02-11-23.
- WHO. Statement on the antigen composition of COVID-19 vaccines. 18 May 2023.
- WHO. Statement on the antigen composition of COVID-19 vaccines. 13 December 2023.
- WHO. Statement on the antigen composition of COVID-19 vaccines. 26 April 2024.
Class
Hosted Content 2
Why recognising the signs of dehydration is important...
Saturday 1 February 2025, 08:30 AM
2 minutes to Read
Latest issue
